Articles dans des revues avec comité de lecture (167)
  1. 164. Fruhling, J., Coune, A., Ghanem, G. E., Sculier, J.-P., Verbist, A., Brassinne, C., Laduron, C., & Hildebrand, J. (1984). Distribution in man of 111In-labelled liposomes containing a water-insoluble antimitotic agent. Nuclear medicine communications, 5(4), 205-208.
  2. 165. Coune, A., Sculier, J.-P., Fruhling, J., Stryckmans, P., Brassinne, C., Ghanem, G. E., Laduron, C., Atassi, G., Ruysschaert, J. M., & Hildebrand, J. (1983). Iv administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to man. Cancer treatment reports, 67(11), 1031-1033.
  3. 166. Libert, A., Ghanem, G. E., Arnould, R., Vercammen Grandjean, A., Carrel, S., & Lejeune, F. (1983). Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution. Anticancer research, 3(4), 219-225.
  4. 167. Ghanem, G. E., Legros, F., Lejeune, F., & Fruhling, J. (1982). Comparison and evaluation of different methods for alpha-MSH labelling. Journal of immunological methods, 54(2), 223-232.
    5.   Communications publiées lors de congrès ou colloques nationaux et internationaux (8)
  5. 1. Rezai, K., Bourgeois, P., Ghanem, G. E., Kahatt, C., de Valeriola, D., et al. (2005). Pharmacokinetics, metabolism, and routs of excretion of intravenous (14 C)-irofulven in patients with advanced solid tumors. Clinical for Cancer Research. Vol. 46 (p. 939) 96th Annual Meeting AACR(2005: Anaheim CA, Etats-unis).
  6. 2. Kinnaert, E., Duez, P., Dubois, J., & Ghanem, G. E. (2002). Measurement of radio-induced DNA damage in human melanoma cells. European Standards Committee on Oxidative DNA Damage Workshop (du 14 au 16 mars 2002: Valencia, Espagne)
  7. 3. Süli-Varga, H., Nadasi, H., Mihala, N., Morandini, R., & Ghanem, G. E. (2001). Synthesis and biological activity of double cyclic RGD containing peptides. In J. Martinez & J. A. Fehrentz (Eds.), Peptides 2000, proceedings of the 26th European Peptide Symposium (pp. 749-750) Paris: EDK éditions médicales et scientifiques.
  8. 4. Vandeweyer, E., Vico, P., Nogaret, J.-M., Hertens, D., Ghanem, G. E., & Deraemaecker, R. (1994). Mastectomy and immediate reconstruction: a good option ? In E. Kubista, A. Staffen, & C. C. Zielinski (Eds.), 2nd European Congress on Senology, breast diseases, of the Senologic International Society (S.I.S.) (pp. 469-472) Bologna, Italy: Monduzzi Editore S.p.A.
  9. 5. Jacquemotte, F., Ghanem, G. E., Lejeune, F., Faignet, C., Deknop, C., Toch, I., Devreese, B., & Van Beeumen, J. (1993). Study of new alpha-MSH analogues carrying nitrogen mustard at their N-terminus for human melanoma targeting by electrospray mass spectrometry. In C. Schneider & A. Eberle (Eds.), Peptides 1992 (pp. 379-380) ESCOM Science Publishers B.V.
  10. 6. Ghanem, G. E., Guenier, C., Gebhart, M., & Lejeune, F. (1989). Treatment of bone metastases of the peripheral skeleton: a review of 62 cases. ECCO 5 (3-7 septembre: London)
  11. 7. Ghanem, G. E., Libert, A., Arnould, R., Vercammen, A., & Lejeune, F. (1985). Binding of the alpha melanocyte stimulating hormone to human melanoma cells in culture. In Pigment cell 1985. Proceedings of the 12th Internationational Pigment Cell Conference (pp. 175-181) Tokyo University Press.
  12. 8. Ghanem, G. E., Gossuin, A., Temmerman, A., Coel, J., Henry, P., & Legros, F. (1981). 125I α MSH binding in human melanoma cell lines. In Colloqium on Protides of the biological fluids (pp. 555-558) Peeters.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>